Marc D Beer
Insider
First SEC filing: June 10, 2026 · Latest: June 10, 2026
Insider at
Insider transactions
2 buys (P)
0 sells (S)
Net: $202,204
Avg return of open purchases vs now: -25.3%
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 11, 2026 | BTMD | P | 16,000 | $1.55 | $24,800 | 239,744 Direct | +7.15% | Acquired | -25.8% (price as of 2026-10-02) |
| Aug. 10, 2026 | BTMD | P | 115,950 | $1.53 | $177,404 | 223,744 Direct | +107.57% | Acquired | -24.8% (price as of 2026-10-02) |
| June 8, 2026 | BTMD | A | 114,157 | · | · | 114,157 Direct | · | Acquired | (price as of 2026-10-02) |
| May 12, 2026 | BTMD | A | 195,000 | · | · | 195,000 Direct | · | Acquired | (price as of 2026-10-02) |
| April 1, 2025 | BTMD | A | 495,600 | · | · | 495,600 Direct | · | Acquired | (price as of 2026-10-02) |
| March 17, 2025 | BTMD | P | 107,794 | $3.87 | $417,163 | 107,794 Direct | · | Acquired | -70.3% (price as of 2026-10-02) |
| April 1, 2024 | BTMD | A | 543,958 | · | · | 1,338,842 Direct | +68.43% | Acquired | (price as of 2026-10-02) |
| May 17, 2023 | BTMD | A | 317,163 | · | · | 794,884 Direct | +66.39% | Acquired | (price as of 2026-10-02) |
| Jan. 9, 2023 | BTMD | S | 865,384 | $3.00 | $2,596,152 | 0 Direct | -100.00% | Disposed | -61.7% (price as of 2026-10-02) |
| Jan. 6, 2023 | BTMD | C | 865,384 | · | · | 865,384 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 6, 2023 | BTMD | J | 865,384 | · | · | 2,967,092 Direct | -22.58% | Disposed | (price as of 2026-10-02) |
| Jan. 6, 2023 | BTMD | C | 865,384 | · | · | 2,967,092 Direct | -22.58% | Disposed | (price as of 2026-10-02) |
| Nov. 15, 2022 | BTMD | A | 477,721 | · | · | 477,721 Direct | · | Acquired | (price as of 2026-10-02) |
| Nov. 15, 2022 | BTMD | A | 477,721 | · | · | 477,721 Direct | · | Acquired | (price as of 2026-10-02) |
| May 26, 2022 | BTMD | J | 654,387 | · | · | 3,832,476 Direct | +20.59% | Acquired | (price as of 2026-10-02) |
| May 26, 2022 | BTMD | J | 654,387 | · | · | 3,832,476 Direct | +20.59% | Acquired | (price as of 2026-10-02) |
| May 26, 2022 | BTMD | J | 654,387 | · | · | 3,832,769 Direct | +20.59% | Acquired | (price as of 2026-10-02) |
| May 26, 2022 | BTMD | A | 3,178,089 | · | · | 3,178,089 Direct | · | Acquired | (price as of 2026-10-02) |
| May 26, 2022 | BTMD | J | 654,387 | · | · | 3,832,769 Direct | +20.59% | Acquired | (price as of 2026-10-02) |
| May 26, 2022 | BTMD | A | 3,178,089 | · | · | 3,178,089 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 31, 2018 | NERV | D | 80,356 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Jan. 31, 2018 | NERV | A | 12,500 | · | · | 12,500 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 31, 2018 | NERV | D | 12,500 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Jan. 31, 2018 | NERV | A | 12,500 | · | · | 12,500 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 31, 2018 | NERV | D | 12,500 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Jan. 31, 2018 | NERV | A | 7,500 | · | · | 7,500 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 31, 2018 | NERV | D | 7,500 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Jan. 31, 2018 | NERV | A | 127,513 | · | · | 127,513 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 31, 2018 | NERV | D | 127,513 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Jan. 31, 2018 | NERV | A | 80,356 | · | · | 80,356 Direct | · | Acquired | (price as of 2026-10-02) |
| June 1, 2017 | NERV | A | 12,500 | · | · | 12,500 Direct | · | Acquired | (price as of 2026-10-02) |
| March 20, 2017 | NERV | P | 25,000 | $7.89 | $197,250 | 50,000 Direct | +100.00% | Acquired | -94.8% (price as of 2026-10-02) |
| March 17, 2017 | NERV | P | 25,000 | $8.34 | $208,500 | 25,000 Direct | · | Acquired | -95.1% (price as of 2026-10-02) |
| June 16, 2016 | NERV | A | 12,500 | · | · | 12,500 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 2, 2015 | NERV | A | 7,500 | · | · | 7,500 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 2, 2015 | NERV | A | 7,500 | · | · | 7,500 Direct | · | Acquired | (price as of 2026-10-02) |
| June 30, 2014 | NERV | A | 127,513 | · | · | 127,513 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 8, 2026 | BTMD | Employee Stock Option (Right to Buy) | Class A Common Stock | $2.34 | June 7, 2036 | 114,157 | Acquired |
| May 12, 2026 | BTMD | Stock Option (Right to Buy) | Class A Common Stock | $2.20 | May 11, 2036 | 195,000 | Acquired |
| April 1, 2025 | BTMD | Employee Stock Option (Right to Buy) | Class A Common Stock | $3.63 | March 31, 2035 | 495,600 | Acquired |
| April 1, 2024 | BTMD | Employee Stock Option (Right to Buy) | Class A Common Stock | $5.72 | March 31, 2034 | 543,958 | Acquired |
| May 17, 2023 | BTMD | Stock Option (Right to Buy) | Class A Common Stock | $5.83 | May 16, 2033 | 317,163 | Acquired |
| Jan. 6, 2023 | BTMD | Retained Biote Units | Class A Common Stock | · | · | 865,384 | Disposed |
| Nov. 15, 2022 | BTMD | Stock Option (Right to Buy) | Class A Common Stock | $3.97 | Nov. 14, 2032 | 477,721 | Acquired |
| Nov. 15, 2022 | BTMD | Stock Option (Right to Buy) | Class A Common Stock | $4.04 | Nov. 14, 2032 | 477,721 | Acquired |
| May 26, 2022 | BTMD | Retained Biote Units | Class A Common Stock | · | · | 654,387 | Acquired |
| May 26, 2022 | BTMD | Retained Biote Units | Class A Common Stock | · | · | 654,387 | Acquired |
| May 26, 2022 | BTMD | Retained Biote Units | Class A Common Stock | · | · | 3,178,089 | Acquired |
| Jan. 31, 2018 | NERV | Stock Option (Right to Buy) | Common Stock | $9.49 | Dec. 19, 2023 | 80,356 | Disposed |
| Jan. 31, 2018 | NERV | Stock Option (Right to Buy) | Common Stock | $10.20 | Jan. 31, 2020 | 12,500 | Acquired |
| Jan. 31, 2018 | NERV | Stock Option (Right to Buy) | Common Stock | $10.00 | May 31, 2027 | 12,500 | Disposed |
| Jan. 31, 2018 | NERV | Stock Option (Right to Buy) | Common Stock | $10.00 | Jan. 31, 2020 | 12,500 | Acquired |
| Jan. 31, 2018 | NERV | Stock Option (Right to Buy) | Common Stock | $10.20 | June 15, 2026 | 12,500 | Disposed |
| Jan. 31, 2018 | NERV | Stock Option (Right to Buy) | Common Stock | $4.34 | Jan. 31, 2020 | 7,500 | Acquired |
| Jan. 31, 2018 | NERV | Stock Option (Right to Buy) | Common Stock | $4.34 | Feb. 1, 2025 | 7,500 | Disposed |
| Jan. 31, 2018 | NERV | Stock Option (Right to Buy) | Common Stock | $6.00 | Jan. 31, 2020 | 127,513 | Acquired |
| Jan. 31, 2018 | NERV | Stock Option (Right to Buy) | Common Stock | $6.00 | June 29, 2024 | 127,513 | Disposed |
| Jan. 31, 2018 | NERV | Stock Option (Right to Buy) | Common Stock | $9.49 | Jan. 31, 2020 | 80,356 | Acquired |
| June 1, 2017 | NERV | Stock Option (Right to Buy) | Common Stock | $10.00 | May 31, 2027 | 12,500 | Acquired |
| June 16, 2016 | NERV | Stock Option (right to buy) | Common Stock | $10.20 | June 15, 2026 | 12,500 | Acquired |
| Feb. 2, 2015 | NERV | Stock Option (right to buy) | Common Stock | · | Feb. 1, 2025 | 7,500 | Acquired |
| Feb. 2, 2015 | NERV | Stock Option (right to buy) | Common Stock | · | Feb. 1, 2015 | 7,500 | Acquired |
| June 30, 2014 | NERV | Stock Option (Right to Buy) | Common Stock | $6.00 | June 29, 2024 | 127,513 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $156,934 | · | · | · | $104,418 | · | $42,500 | $1,406,783 |
| 2024 | $433,052 | · | · | · | $261,114 | · | $413 | $2,675,601 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.